Alnylam Pharmaceuticals is founded in 2002, operates from its headquarter in 675 W Kendall St Cambridge, Massachusetts 02142, US. The company operates in the Manufacturing, Pharmaceuticals sector, providing Pharmaceutical Company, Laboratories: Research & Testing, and more to its customers. Currently, Alnylam Pharmaceuticals is a international company

Alnylam Pharmaceuticals specializes in RNA interference (RNAi), Gene silencing, Therapeutic drug development, and offers services including RNAi therapeutics, Commercial medicine, and RNAi therapeutic.

Alnylam Pharmaceuticals has hired 73 new employees in the past 6 months, including 19 C-level executives. During the past 6 months, 74 employees departed, with 13 leaving from C-level positions.